NCT07613229已完成不适用
Cross-Sectional Assessment of Cardiovascular Risk Among ESC Congress 2025 Participants
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,366
- 试验地点
- 1
研究概览
简要总结
The European Society of Cardiology (ESC) is dedicated to promoting cardiovascular (CV) health and minimizing the occurrence of cardiovascular diseases throughout Europe. As a founding member of the European Alliance for Cardiovascular Health (EACH), the ESC is advocating for European and National Cardiovascular Health Plans which would include a cardiovascular and diabetes health check as part of a screening process for citizens. In line with this call for public health diagnosis of CV health, the ESC is committed to raising awareness on the need for actions and proposes to offer complimentary tests to delegates at ESC Congress 2025 in Madrid.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •All healthcare professionals (doctors, nurses, etc.) attending the ESC Congress 2025 from August 29th to September 1st
- •Subjects who declare that they are able to understand and give IC in English
排除标准
- •Subjects not willing to provide his/her consent to participate in the study.
- •Subjects who are not suitable candidates for blood extraction.
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Cardiovascular risk assessment among adults residing in selected areas of urban communityCTRI/2025/08/092891College of Nursing275
尚未招募
不适用
A Study on Heart Disease Risk Using Cholesterol Tests and Physical Fitness Tests in Adults Aged 25–60 Years.CTRI/2026/01/101030Rajath113
尚未招募
不适用
Using a heart health app to detect early risks of heart disease, diabetes, hypertension and sleep disorders in healthy individuals.CTRI/2025/08/093780Philips Global Business Services1,000
招募中
不适用
Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental ComplicationsNCT07356817Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1,260
已完成
不适用
A study to assess the cardiovascular disease risk in Indian patientsCTRI/2024/02/062577Sun Pharma Laboratories Ltd.4,500
